Cristina Estornut

Cristina Estornut

Auto-generated profile, based on publicly available information

Cristina Estornut

FIBIO Research Group, Department of Physiotherapy, Faculty of Health Sciences, European University of Valencia, Valencia, Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2024 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
CECristina Estornut
Cristina Estornut
GRGiulia Rinaldi
Giulia Rinaldi
MCMaría Carmen Carceller
María Carmen Carceller
SESergio Estornut
Sergio Estornut
MPMartín Pérez-Leal
Martín Pérez-Leal

20 April 2023 in Heliyon
Verified
Journal Article
Open access
PMPaula Montero
Paula Montero
IRInés Roger
Inés Roger
CECristina Estornut
Cristina Estornut
JMJavier Milara
Javier Milara
JCJulio Cortijo
Julio Cortijo
N-Acetyl-l-cysteine (NAC) acts as a precursor of the tripeptide glutathione (GSH), one of the principal cell mechanisms for reactive oxygen species (ROS) detoxification. Chronic obstructive pulmonary disease (COPD) is associated with enhanced inflammatory response and oxidative stress and NAC has been used to suppress various pathogenic processes in this disease. Studies show that the effects of NAC are dose-dependent, and it appears that the efficient doses in vitro are usually higher than the achieved in vivo plasma concentrations. However, to date, the inconsistencies between the in vitro NAC antioxidant and anti-inflammatory in vitro effects, by reproducing the in vivo NAC plasma concentrations as well as high NAC concentrations. To do so, A549 were transfected with polyinosinic-polycytidylic acid (Poly (I:C)) and treated with NAC at different treatment periods. Oxidative stress, release of proinflammatory mediators and NFkB activation were analyzed. Results suggest that NAC at low doses in chronic administration has sustained antioxidant and anti-inflammatory effects, while acute treatment with high dose NAC exerts a strong antioxidant and anti-inflammatory response.

28 December 2023 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
MPMartín Pérez-Leal
Martín Pérez-Leal
FLFederico Lanciano
Federico Lanciano
NFNicla Flacco
Nicla Flacco
CECristina Estornut
Cristina Estornut
MCMaría Carmen Carceller
María Carmen Carceller

3 March 2026 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ILInés Roger Laparra
Inés Roger Laparra
CECristina Estornut
Cristina Estornut
PMPaula Montero
Paula Montero
MAMónica Aparici
Mónica Aparici
CPCarlos Puig
Carlos Puig
JCJulio Cortijo
Julio Cortijo

30 September 2025 in International Journal of Cancer
Verified
Journal Article
Closed access
MPMartín Pérez-Leal
Martín Pérez-Leal
CECristina Estornut
Cristina Estornut
LALourdes Alfaro‐Ochoa
Lourdes Alfaro‐Ochoa
GSGermán Sánchez‐Herrera
Germán Sánchez‐Herrera
IRInés Roger
Inés Roger
NFNicla Flacco
Nicla Flacco

21 December 2025 in Journal of Oral Microbiology
Verified
Journal Article
Open access
MPMartín Pérez-Leal
Martín Pérez-Leal
MNMatteo Nakhle
Matteo Nakhle
CECristina Estornut
Cristina Estornut
GSGermán Sánchez-Herrera
Germán Sánchez-Herrera
PRPilar Ribera
Pilar Ribera
NFNicla Flacco
Nicla Flacco
Dental caries prevention can be approached through ecological modulation of the oral biofilm. Among oral probiotics, Streptococcus dentisani stands out for its arginine deiminase (ADI) pathway, producing ammonia with an alkalinizing effect, and for bacteriocins active against cariogenic organisms, suggesting restoration of acid–base homeostasis and displacement of dysbiosis-associated taxa. To systematically review clinical evidence on S. dentisani and other probiotics regarding their effects on pH modulation and oral microbiota shifts. A PRISMA-guided systematic review of PubMed, Scopus, and Web of Science was conducted, including randomized controlled trials (RCTs) and observational studies reporting at least one prespecified outcome (pH or microbiota). Two clinical studies specifically assessed S. dentisani, reporting transient oral colonization, increased salivary alkalinity, and reductions in S. mutans, with one trial documenting a favorable community shift by 16S sequencing. Across the remaining studies, which mainly involved Lactobacillus and Bifidobacterium strains, nine reported reductions in cariogenic markers and five reported increases in pH/buffering capacity; these findings do not pertain to S. dentisani but to other probiotic strains. Caries incidence was evaluated only in lactic probiotic trials with mixed findings; no caries-incidence data were available for S. dentisani. S. dentisani demonstrates consistent mechanistic benefits—pH increase and modulation of the oral microbiota—supporting its candidacy as an oral probiotic. Evidence on caries prevention remains insufficient, underscoring the need for longer, standardized trials incorporating clinical endpoints and microbiological profiling.